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Many histone acetyltransferases undergo autoacetylation, either through chemical or enzymatic means, to potentiate enzymatic cognate substrate lysine acetylation, although the mode and molecular role of such autoacetylation is poorly understood. The MYST family of histone acetyltransferases is autoacetylated at an active site lysine residue to facilitate cognate substrate lysine binding and acetylation. Here, we report on a detailed molecular investigation of Lys-274 autoacetylation of the human MYST protein Males Absent on the First (hMOF). A mutational scan of hMOF Lys-274 reveals that all amino acid substitutions of this residue are able to bind cofactor but are significantly destabilized, both in vitro and in cells, and are catalytically inactive for cognate histone H4 peptide lysine acetylation. The x-ray crystal structure of a hMOF K274P mutant suggests that the reduced stability and catalytic activity stems from a disordering of the residue 274-harboring a ␣2-␤7 loop. We also provide structural evidence that a C316S/E350Q mutant, which is defective for cognate substrate lysine acetylation; and biochemical evidence that a K268M mutant, which is defective for Lys-274 chemical acetylation in the context of a K274-peptide, can still undergo quantitative K274 autoacetylation. Together, these studies point to the critical and specific role of hMOF Lys-274 autoacetylation in hMOF stability and cognate substrate acetylation and argues that binding of Ac-CoA to hMOF likely drives Lys-274 autoacetylation for subsequent cognate substrate acetylation.
Lysine acetylation is a post-translational modification that is linked to numerous regulatory functions in both the nucleus and cytoplasm of the cell. Although histones were long known to be acetylated to regulate chromatin dynamics and functions for DNA-templated activities, more recent acetylomic studies have revealed that thousands of other diverse proteins are acetylated throughout the proteome to regulate a broad range of cellular functions (1) (2) (3) (4) . Acetyltransferases are the enzymes that carry out acetylation. The most extensively studied of these enzymes are the histone acetyltransferases (HATs), 2 which are divided into at least five subfamilies based on sequence homology and substrate preferences. They are HAT1, GCN5/PCAF, MYST, p300/CBP, and Rtt109. These acetyltransferases all share a conserved acetyl-coenzyme A (Ac-CoA) binding core region but differ in their core flanking regions, which contribute to HAT-specific activities (5) . All but the MYST family of HATs have been demonstrated to proceed through a ternary catalytic mechanism whereby both Ac-CoA and cognate lysine substrates must simultaneously bind for acetyl-transfer (6 -9) .
The mode of cognate substrate lysine acetylation by MYST proteins has been previously addressed. MYST proteins have been demonstrated to acetylate cognate substrates through a ping-pong catalytic mechanism, whereby Ac-CoA binds first to transfer the acetyl group to an active site cysteine residue (Cys-316 in hMOF) to form an acetyl-enzyme intermediate prior to acetyl-transfer to the cognate lysine substrate. An active site glutamate residue (Glu-350 in hMOF) is proposed to serve as a general base for catalysis for both active site cysteine and cognate lysine substrate deprotonation (10) . However, another study demonstrates that the yeast Esa1 member of the MYST family, when assembled within a physiologically relevant piccolo NuA4 complex, shows a strong catalytic dependence on the corresponding active site glutamate residue, but not the active site cysteine residue, suggesting that yeast Esa1 within the piccolo NuA4 complex proceeds through a ternary catalytic mechanism similar to the other HAT families (11) .
PCAF, the MYST family, p300, and Rtt109 are all known to be regulated by lysine autoacetylation, either through chemical or enzymatic means (12) (13) (14) (15) (16) (17) (18) (19) . Interestingly, despite the commonality of this automodification among the acetyltransferases, the mechanism of regulation appears to vary between the proteins (20) . For PCAF autoacetylation at lysines 416, 428, 430, 441, and 442 leads to increased structural stability and * This work was supported, in whole or in part, by National Institutes of Health Grants R01 GM060293 and P01 AG031862 (to R. M. and B. J.) and T32 GM008275 (to C. E. M.), and a predoctoral fellowship grant from the American Heart Association (to S. S.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. catalytic activity, as well localization regulation (13, 21) . In the case of p300, several lysine residues within a proteolytically sensitive loop become autoacetylated, leading to a decreased K m for both substrate and cofactor as well as an increased catalytic rate. Autoacetylation of lysine 290 of Rtt109, located about 8 Å away from the enzyme active site, potentiates Rtt109 catalytic activity by decreasing the K m for Ac-CoA and increasing the rate of catalysis (19) .
Within the MYST family of acetyltransferases, autoacetylation of a conserved active-site lysine residue (Lys-274 in hMOF) has been demonstrated to potentiate enzyme activity (14 -17) . The specific chemical nature of the acetyllysine has also been shown to be critical as a glutamine substitution does not serve as an acetyllysine mimic (16) . Kinetic studies of Tip60 MYST protein have demonstrated that autoacetylation increases k cat (17) . In the case of dMOF, mutation of the corresponding lysine residue to alanine leads to a decreased thermal stability of the enzyme (22) and biochemical studies of hMOF have shown that mutations of lysine 274 to alanine or arginine compromises substrate binding (16) . Crystal structures of hMOF reveal that Lys-274 within the ␣2-␤7 loop can take on different conformations depending on its acetylation state. When Lys-274 is acetylated, it points into the enzyme active site such that the acetyl carbonyl makes a hydrogen bond to a serine residue and the acetyl methyl group makes a van der Waals interaction to a phenylalanine residue in the active site, with the aliphatic part of the acetyllysine in position to contribute to the cognate lysine for substrate acetylation. When Lys-274 is unacetylated it adopts a position, which is flipped out of the active site about 90°relative to acetylated Lys-274, such that Lys-274 hydrogen bonds to the Glu-350 general base to sterically occlude cognate lysine binding and acetylation (16) .
The mode of Lys-274 acetylation has been proposed to proceed through enzymatic autoacetylation intramolecularly (in cis), which is consistent with the proximity of acetylated Lys-274 in the enzyme active site (14, 16) . However, this acetylation has also been shown to be independent of the Glu-350 general base residue and we have recently shown that a 19-residue hMOF peptide (261-279) can undergo chemical (i.e. non-enzymatic) acetylation at Lys-274 with elevated Ac-CoA concentrations (23). This finding is consistent with recent studies by us and others that lysine residues near an appropriately positioned basic residue or basic patch within proteins have elevated capacities for chemical acetylation (23, 24) . For MYST proteins, a conserved lysine residue is found six residues N-terminal to Lys-274, and we showed that an hMOF peptide with the corresponding native Lys-268 or K268R mutation can undergo chemical acetylation, whereas a K268M mutant cannot (23).
These findings leave open the possibility that hMOF Lys-274 autoacetylation may happen non-enzymatically to "prime" the enzyme for cognate substrate acetylation. In this study, we aimed to obtain a more comprehensive understanding of the role and mode of Lys-274 autoacetylation in hMOF function.
Results

No Other Amino Acid Substitution at Position 274 in hMOF Can Mimic the Potentiating Role of Lys-274 Acetylation on hMOF Thermal Stability and Cognate Lysine Substrate
Acetylation-Because lysine 274 has been shown to have roles in both protein stability and substrate binding and acetylation in vitro, we sought to determine whether other amino acids could mimic the effect of Lys-274 autoacetylation. To do so, we prepared recombinant His 6 -tagged wild-type and mutated hMOF HAT domains containing Lys-274 mutated to every other natural amino acid to assess protein thermostability and catalytic activity. Following affinity purification using the His 6 tag, the wild-type and mutant proteins eluted off of a size exclusion column at the same position, suggesting that the mutant proteins were properly folded ( Fig. 1 ). Each mutant was tested for catalytic activity, and to ensure that the Lys-274 mutation was not merely affecting catalysis by changing the pK a of the active site of the enzyme, activity was tested over a range of pH values (Fig. 2) . Strikingly, these studies revealed that every Lys-274 mutant protein was significantly defective for cognate lysine acetylation, retaining less than 5% of wild-type activity.
To test the thermal stability of the Lys-274 hMOF mutants, each one was tested in a thermal denaturation assay. All mutants produced a melting curve revealing an average loss of 9.3°C in thermal stability (with the exception of K274L, which did not produce a curve from which an inflection point could be calculated) relative to wild-type hMOF ( Table 1 and Fig. 3A) . Interestingly, however, upon addition of 100 M coenzyme A (CoA) cofactor, the stability of the mutants increased an average of 7.9°C and wild-type hMOF stability increased by 6°C FIGURE 1. Size exclusion chromatograms of hMOF K274 mutants suggests that they are properly folded. UV chromatograms of a representative subset of hMOF Lys-274 mutants applied to HiLoad Superdex 75 16/60 gel filtration column. Each mutant displayed a similar profile and the major peak at ϳ75 ml was collected.
( Fig. 3B and Table 1 ). These results demonstrate that the hMOF Lys-274 mutants have compromised thermal stability relative to the wild-type protein but still retain the capacity for binding cofactor.
To assess whether the effect of the hMOF Lys-274 mutations are general to other MYST proteins, we prepared a subset of hMOF mutants in the recombinant MYST hMOZ HAT domain for enzymatic and thermal stability studies. These studies demonstrate that of the subset of corresponding Lys-604 mutations (to Ala, Arg, Met, and Gln) tested, all of them had significantly compromised catalytic activity for cognate lysine acetylation ( Fig. 4A ) and thermal stability relative to wild-type hMOZ ( Fig. 4B and Table 1 ). This result suggests that the importance of Lys-274 acetylation on hMOF activity and thermal stability is likely general to other MYST proteins. It should be noted, however, that the degree of protein stabilization mediated by autoacetylation at this position may vary from protein to protein within the MYST family.
Crystal Structure of hMOF K274P Reveals Loss of Rigidity of the ␣2-␤7 Loop-To understand the molecular basis for the compromised catalytic activity and thermal stability of the hMOF Lys-274 mutants relative to the wild-type protein, we attempted to obtain crystals of each of the hMOF Lys-274 HAT domain mutants for x-ray structure determination. We were only able to obtain crystals of the hMOF-K274P HAT domain mutant, which formed in space group P2 1 2 1 2 1 with one molecule in the asymmetric unit and diffracted to 2.6-Å resolution. The structure was refined to an R work /R free of 24.0/27.6% with good geometry ( Table 2 ). The structure overlays very well with the wild-type hMOF HAT domain (PDB code 3QAH) with a FIGURE 2. All hMOF Lys-274 mutants are catalytically inactive. Relative enzymatic activity of hMOF Lys-274 mutants in comparison to wild-type hMOF over a pH range from 5 to 9 measured as a function of H4 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) peptide acetylation is shown. hMOF-WT activity at pH 8.0 is set to 1. All mutants retain less than 5% wild-type enzymatic activity. Error bars represent standard deviations determined from quadruplicate measurements. root mean square deviation of 0.85 Å 2 (excluding the ␣2-␤7 loop). Strikingly, in contrast to the wild-type hMOF structure containing the acetylated Lys-274, which shows ordered electron density corresponding to the ␣2-␤7 loop (Fig. 5A) , the hMOF-K274P mutant shows no clear density for the ␣2-␤7 loop (Fig. 5B ). These studies suggest that hMOF Lys-274 acetylation contributes to the integrity of the ␣2-␤7 loop of the activated protein. Notably, the active site Cys-316 and Glu-350 residues of hMOF-K274P are in the same position as in the wild-type structure (Fig. 4C) , demonstrating that the ␣2-␤7 loop and acetylated Lys-274 do not contribute to orienting the key catalytic active site residues. Although it is also possible that the introduction of a proline residue, rather than loss of acetyllysine could be responsible for the disorder of the ␣2-␤7 loop, the observation that the hMOF K274P has a similar thermal stability to all other hMOF Lys-274 mutants suggests that the absence of acetyllysine at least contributes to the observed disorder of the ␣2-␤7 loop.
Autoacetylation of Lys-274 Does Not Require Active Site Catalytic Residues Cys-316 and Glu-350 -To investigate the mode of Lys-274 autoacetylation, we prepared a hMOF C316S/ E350Q HAT domain double mutant and asked whether this mutant is capable of Lys-274 autoacetylation. We first prepared hMOF C316S/E350Q in bacteria and confirmed that this mutant had no detectable activity against a cognate substrate lysine in the form of a 19-residue histone H4 N-terminal peptide, whereas the wild-type hMOF HAT domain showed robust activity (Fig. 6A) . To determine the Lys-274 autoacetylation state of hMOF C316S/E350Q, we performed a Western blotting analysis using a pan-acetyllysine antibody, which indicated that the hMOF C316S/E350Q mutant was acetylated ( Fig. 6B ). We also crystallized this mutant and determined its structure to 2.17-Å resolution. The structure was refined to an R work /R free of 19.1/23.4% with good geometry (Table 2) . Strikingly, the refined structure revealed that Lys-274 was acetylated with full occupancy (Fig. 6C ). This observation demonstrates that Lys- We have previously demonstrated that an isolated peptide of the ␣2-␤7 loop can be chemically acetylated at residue Lys-274 and that the basic nature of native residue Lys-268 or a mutant residue Arg-268 supports Lys-274 autoacetylation, and an uncharged K268M mutant does not (23) . To test the importance of Lys-268 for Lys-274 autoacetylation and subsequent hMOF cognate lysine substrate acetylation in the context of the folded hMOF HAT domain, we prepared the recombinant hMOF K268M HAT domain mutant for enzymatic analysis against a histone H4 cognate lysine substrate for comparison with the wild-type hMOF HAT domain. Surprisingly, the kinetic parameters for the wild-type and K268M mutant enzyme are remarkably similar (Fig. 7) . A Western blotting analysis using a pan-acetyllysine antibody confirmed that the hMOF K268M mutant is autoacetylated at wild-type levels (Fig.  6B) . These results suggest that in the context of the folded hMOF HAT domain, Lys-268 does not contribute significantly to Lys-274 autoacetylation and that autoacetylation may be promoted by Ac-CoA binding and positioning for effective Lys-274 autoacetylation.
Autoacetylation of Lys-274 Increases hMOF Half-life in Cells-Our findings that Lys-274 autoacetylation plays a specific and precise role in thermal stability of the hMOF HAT domain in vitro led us to ask whether Lys-274 acetylation is required for hMOF protein stability in cells. To measure the stability of hMOF and hMOF (K274R) within cells, we expressed V5-tagged versions of the proteins under the control of a Tet-On promoter. Doxycycline was added to induce steady-state levels of the proteins, and then the rate of protein decay was followed after removal of doxycycline and the addi- tion of cyclohexamide to block protein synthesis. hMOF-K274R decayed more rapidly than the wild-type protein (Fig.  8A) . The mutant protein also decayed more rapidly than wildtype when the experiment was performed without cyclohexamide, thus ruling-out potential contributions from other effects of the drug (e.g. inhibition of autophagy) (Fig. 8B) . These findings demonstrate that the K274R mutation destabilizes hMOF in vivo, and indicate that hMOF K274 autoacetylation contributes to protein stability in cells.
Discussion
The results described here reveal that an autoacetylated lysine residue at position 274 of hMOF contains the essential specific chemical properties to promote hMOF stability and activity. Strikingly, we find that hMOF Lys-274 autoacetylation cannot be mimicked by other residues, arguing for the unique chemical properties of an autoacetylated Lys-274 residue in hMOF catalysis. Although previous reports have proposed that hMOF Lys-274 autoacetylation may be required to "unlock" the protein off-state by making the general base Glu-350 available for the catalytic reaction and making the cognate lysine substrate binding site more accessible (14, 16) , we have found that mutations of Lys-274 to very small amino acids such as glycine or alanine do not activate the protein. This data would suggest that hMOF Lys-274 autoacetylation also plays a more direct positive role than merely counteracting reactivity in the off-state. All but one of the hMOF Lys-274 mutants were demonstrated to bind CoA, and the K274P crystal structure reveals that the key Cys-316 and Glu-350 catalytic residues are unperturbed. The ␣2-␤7 loop, however, was observed to be disordered in the hMOF-K274P structure, consistent with the loss of thermal stability for the Lys-274 mutants in vitro and the reduced half-life to hMOF-K274R in cells. These observations demonstrate that in addition to facilitating cognate lysine substrate binding (16) , hMOF Lys-274 autoacetylation promotes protein stability to also indirectly contribute to cognate lysine substrate catalysis. We previously reported on a structure of hMOF in which the ␣2-␤7 loop could be modeled in two alternate conformations, one in which Lys-274 was acetylated and another where Lys-274 was unacetylated (16) . Interestingly, the ␣2-␤7 loop could be traced in both cases, however, Lys-274 refined to a higher B-factor in the unacetylated relative to acetylated form, 36.6 versus 30.9 Å 2 , respectively, consistent with the greater rigidity of the ␣2-␤7 loop when Lys-274 is acetylated.
Although autoacetylation of hMOF Lys-274 has been demonstrated to be required for cognate histone substrate binding (16) , no MYST family proteins have been crystallized with their cognate lysine peptide substrates. To gain insights into how hMOF might recognize its cognate substrate and how the Lys-274-containing ␣2-␤7 loop might participate in this recognition, we aligned the structurally similar Hat1 HAT of the Hat1/ Hat2/H4 peptide crystal structure (PDB code 4PSW) with hMOF (PDB code 3QAH). This superposition demonstrates that a Hat1 loop containing Glu 162 -Asp 168 overlays well with the ␣2-␤7 loop of hMOF ( Fig. 9 ). In the Hat1 structure, four of six residues in this region are shown to make interactions with the H4 peptide (Glu-162, Ala-163, Asn-165, and Ile-167) (30) . We hypothesize that the same trend may extrapolate to the ␣2-␤7 loop of hMOF such that the hMOF ␣2-␤7 loop might be used for cognate histone H4 peptide recognition in a similar way. Similar ideas have been proposed comparing hMOF to Gcn5 bound to H3 substrate (14, 22) . Such a model would explain how disruption of the ␣2-␤7 loop may compromise histone H4 binding for cognate lysine acetylation.
We provide crystallographic evidence that hMOF Lys-274 becomes acetylated in the absence of both known catalytic residues, Cys-316 and Glu-350, which makes a strong argument for the autoacetylation at this position to not be mediated by acid/base catalysis as proposed for cognate lysine substrate acetylation. We have also found that in contrast to the trends seen in hMOF peptides (23) , mutation of the preceding basic residue, Lys-268 in context of the HAT domain, does not appear to affect enzyme activity. Thus the mechanism for the regulation of hMOF Lys-274 appears likely to be driven more by Ac-CoA binding and positioning, potentially to prime hMOF for cognate lysine acetylation.
Experimental Procedures
Protein Expression and Purification-The recombinant hMOF HAT domain (residues 174 -449) with an N-terminal His 6 tag separated by a tobacco etch virus protease recognition site was expressed and purified essentially as previously described with some modifications (16) . Briefly, the plasmid was transformed into Escherichia coli BL21(DE3) codon plus RIL (Stratagene) cells and the protein was overexpressed in TB media, induced with 1 mM isopropyl 1-thio-␤-D-galactopyranoside at OD 0.8 -1.5, and grown at 15°C overnight. The cells were harvested and lysed by sonication in lysis buffer (50 mM HEPES (pH 7.5), 0.5 M NaCl, 2 mM ␤-mercaptoethanol, 5 mM imidazole, 5% glycerol, 0.1% CHAPS, and 1 mM phenylmethylsulfonyl fluoride) followed by centrifugation at 28,000 ϫ g for 30 min at 4°C. The lysate supernatant was loaded onto nickelcharged NTA resin (Qiagen) equilibrated with lysis buffer. The resin was washed with 10 column volumes of lysis buffer containing 25 mM imidazole. The protein was eluted with lysis buffer containing 250 mM imidazole buffer in 10-ml fractions. The eluent was concentrated and injected onto an FPLC using a HiLoad Superdex 75 16/60 gel filtration column using sizing buffer (20 mM HEPES (pH 7.5), 0.5 M NaCl). All hMOF mutants were created using the QuikChange protocol from Stratagene. hMOF mutants were expressed and purified using the same protocols as the wild-type hMOF protein described above.
The recombinant MOZ HAT domain (residues 505-784) with an N-terminal His 6 tag separated by a tobacco etch virus protease recognition site was expressed and purified as follows. The plasmid was transformed into E. coli BL21(DE3) codon plus RIL (Stratagene) cells and the protein was overexpressed in LB media, induced with 1 mM isopropyl 1-thio-␤-D-galactopyranoside at OD 0.6, and grown at 15°C overnight. The cells were harvested and lysed by sonication in lysis buffer (50 mM Tris-HCl (pH 8.0), 0.5 M NaCl, 10 mM ␤-mercaptoethanol, 5 mM imidazole, 5% glycerol, 0.01% Triton X-100, and 1 mM phenylmethylsulfonyl fluoride) followed by centrifugation at 28,000 ϫ g for 30 min at 4°C. The lysate supernatant was then loaded onto nickel-charged NTA resin (Qiagen) equilibrated with lysis buffer and the resin was washed with 10 column volumes of lysis buffer containing 25 mM imidazole. The protein was then eluted with lysis buffer containing 250 mM imidazole buffer in 10-ml fractions. The MOZ His tag was cleaved using a His 6 -tagged tobacco etch virus protease and the MOZ protein was dialyzed overnight into low salt ion exchange buffer (40 mM Tris-HCl, pH 7.0, 50 mM NaCl, 1 mM DTT). The protein solution was then passed over another nickel column to remove tobacco etch virus protease and uncleaved MOZ. The resin was washed with approximately 3 column volumes of low salt ion exchange buffer containing 20 mM imidazole. Flow-through and washes were pooled and loaded onto a 1-ml HiTrap SP cation exchange column (GE Healthcare). The protein was eluted in ion exchange buffer with a salt gradient (50 -1000 mM NaCl). Peak fractions were concentrated and run on a HiLoad Superdex 75 16/60 gel filtration column (GE Healthcare) in sizing buffer (20 mM sodium citrate, pH 5.5, 100 mM NaCl, 1 mM DTT). All MOZ mutants were created using the QuikChange protocol from Stratagene. MOZ mutants were expressed and purified using the same protocols as the wild-type MOZ protein described above.
Enzyme Activity Assays-For comparing the activity of hMOF mutants (or MOZ mutants) to wild-type, a radioactivebased enzymatic assay was employed as previously described (10) . Briefly, 50 nM hMOF or 200 nM MOZ was incubated with 400 M substrate peptide (H4(1-19) peptide for hMOF and H3 (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) (19) Thermal Denaturation Assay-Enzyme solutions at 1 M in 40 mM Tris-HCl (pH 8.0) and 100 mM NaCl were incubated in the presence or absence of 100 M CoA for 30 min followed by addition of a 1:300 dilution of a ϫ5000 concentrate of SYPRO Orange (Molecular Probes by Life Technologies) at a final volume of 20 l in a MicroAmp Optical 384-well reaction plate (Applied Biosystems) sealed with Optical Adhesive Covers (Applied Biosystems). Samples were read using a 7900HT Realtime PCR system (Applied Biosystems) measuring from 20 to 95°C using a 1% ramp rate. The dye was excited at 490 nm and the emission light was recorded at 575 nm.
Western Blotting Analysis for Acetyllysine-Lys-274 acetylation levels of hMOF C316S/E350Q, hMOF K274A, hMOF WT, and hMOF K268M were assessed by Western blotting analysis of purified proteins. The antibodies used were as follows: acetylated lysine (Ac-K-103) mouse mAb, 9681S, lot 11, from Cell Signaling Technology, (1:1000); and goat anti-mouse IgG (HϩL)-HRP conjugate: L1721011, lot 350000839 (1:4000), from Bio-Rad.
Crystal Structure Determination of MYST HAT Domains-All protein crystals were obtained using the hanging drop method at protein concentrations between 6 and 8 mg/ml. Crystals of hMOF-K274P were obtained by first concentrating the protein in the presence of 100 M MG 149 (Selleck Chemicals), then incubated with a 5ϫ molar excess of MG 149 before mixing 1:1 with a reservoir buffer composed of 0.28 M ammonium chloride, 26% PEG 3350, and 0.1 M Bistris (pH 6.5) and incubated over reservoir buffer. Crystals of hMOF-C316S/ E350Q were obtained by incubating protein with a 5ϫ molar excess of MG 149 before mixing 1:1 with a reservoir buffer composed of 0.2 M ammonium chloride, 28% PEG 3350, and 0.1 M Bistris (pH 6.5). Despite the presence of MG 149 in the crystal preparatory conditions, no density for this molecule was observed in the final electron density maps.
All native data sets were collected at APS 23 ID-B. Diffraction data were processed using HKL2000 (25) for hMOF-K274P and XDS (26) for hMOF-C316S/E350Q and the structures were determined using molecular replacement with Phaser (27) . Iterative cycles of manual model building were carried out using Coot (28) and refinement was performed using Phenix (29) . Figures were made using PyMOL (The PyMOL Molecular Graphics System, version 1.2r3pre Schrödinger, LLC).
Cell Studies-DNA fragments encoding V5/His-hMOF and V5/His-hMOF(K274R) were obtained from pcDNA4-based plasmids (16) and cloned into vector pLU-TREmin-MCS-pPURO using restriction sites SalI and AgeI. The rtTA3 gene was cloned into the SalI and BamHI sites of pLU-EF1-MCS-BLAST. pLU-EF1-rtTA3-BLAST and V5/His-hMOF were each used to generate lentivirus by transfection of the plasmids into 293T cells using Lipofectamine 2000 (Invitrogen), according to the manufacturer's guidelines. 293T cells were then infected sequentially with the pLU-EF1-rtTA3-BLAST and V5/His-hMOF lentiviruses using 10 g/ml of blasticidin and 1.5 g/ml of puromycin for selection. 293T cells were maintained in DMEM (with pyruvate, Mediatech) and 10% FBS at 37°C, under 6% CO 2 . V5-hMOF and V5-hMOF (K274R) expression was induced to empirically determined steady-state levels with 750 ng/ml of doxycycline for 4 h. Induction was stopped by removing medium and washing cells in 10 ml of cold PBS. Cells were re-plated in fresh medium in 10-cm plates at a density of 3 ϫ 10 5 cells/ml. A final concentration of 10 g/ml of cycloheximide was added after doxycycline removal.
V5/His-hMOF and V5/His-hMOF (K274R) levels were assessed by Western blotting analysis of lysates. Western blotting detection of actin in a separate region of the same blot was used as a loading control. The antibodies used were as follows: anti-V5, P/N 46 -0705, lot 1707842 from Invitrogen (1:2500); anti-actin (I-19), sc-1616, lot L1108 (1:2500); and donkey antigoat IgG HRP, sc-2020, lot G1615 (1:3000), from Santa Cruz Biotechnology; and rabbit anti-mouse IgG HRP, ab97046, lot GR220045-5 (1:3000), from Abcam. 
